Seeing Is Believing
Currently out of the existing stock ratings of Gregory Fraser, 44 are a BUY (80%), 11 are a HOLD (20%).
Analyst Gregory Fraser, carries an average stock price target met ratio of 42.78% that have a potential upside of 44.07% achieved within 106 days. Previously, Gregory Fraser worked at TRUIST.
Gregory Fraser’s has documented 106 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 09-Oct-2025.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/20/2022. The price target of $11 was fulfilled within 56 days with a profit of $5.46 (98.56%) receiving and performance score of 17.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Aug-2022
3 years 6 months 26 days ago
(23-Aug-2022)
0/1 (0%)
$8.35 (228.77%)
Hold Since 22-Aug-2022
$13
3 years 6 months 27 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy Since 14-Oct-2021
$10
3 years 10 months 4 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy
$12
3 years 11 months 10 days ago
(11-Apr-2022)
0/1 (0%)
$3.91 (48.33%)
Buy
$20
3 years 11 months 10 days ago
(11-Apr-2022)
0/1 (0%)
$11.91 (147.22%)
Which stock is Gregory Fraser is most bullish on?
What Year was the first public recommendation made by Gregory Fraser?